From CRISIL
Jubilant Life Sciences announced that the company has received Credit Rating of 'CRISIL AA/Stable' from CRISIL for the proposed issue of Non-Convertible Debentures of Rs. 350 crore.CRISIL has also reaffirmed credit rating of 'CRISIL A1+' for Commercial Paper Programme of the Company for Rs. 400 crore.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
